Vittoria Colizza

Last updated

Vittoria Colizza is an Italian scientist, research director at INSERM and a specialist in mathematical modeling of infectious disease and computational epidemiology. In particular, she has carried out research on the modeling of seasonal and pandemic flu, Ebola and the COVID-19 pandemic.

Contents

Career

Vittoria Colizza was born in 1978 in Rome, Italy. She earned her undergraduate degree in physics from the University of Rome Sapienza in Italy, in 2001 and her PhD in Statistical and Biological Physics from the International School for Advanced Studies, Italy in 2004. After that, she moved to the United States and conducted postdoctoral research at the University of Indiana in Bloomington from 2004 to 2006 under the direction of Alessandro Vespignani, through a grant from the European Research Council, before becoming a visiting assistant professor at the same institution from 2006 to 2007. [1] [2]

In 2007, Colizza joined the ISI Foundation in Turin, Italy, starting a new lab after receiving the award of a Starting Independent Career Grant in Life Sciences by the European Research Council Ideas Program. Here, she conducted research on the 2009 Influenza A (H1N1) pandemic.

In 2011, Colizza joined the INSERM (French National Institute for Health and Medical Research) in Paris, where she was promoted to Research Director in 2017. She currently leads the EPICx lab at INSERM and works on modeling the spread of emerging infectious diseases using statistical physics, computational sciences and mathematical epidemiology. [3]

Colizza has also been a visiting professor at Tokyo Institute of Technology since 2020.

Research

Collizza is known for her research on infectious disease dynamics and public health, using data-driven mathematical and computational models. Her research focuses on how hosts’ behavior such as contact, commuting, air travel, migration, etc) result in the spread of disease. (CITE ORCID) and applications of her work can be seen in epidemics in humans (e.g. 2009 Influenza A (H1N1) pandemic, Ebola virus epidemic, seasonal flu, COVID-19 pandemic) and in animals (bovine brucellosis and tuberculosis), raising awareness of infectious diseases, providing risk assessment analyses to enable preparedness, mitigation and control of such diseases. [4]

Colizza has played a large role in the COVID-19 pandemic research in 2020. Her research includes predicting trends in importations of the pandemic in France and in Europe and also quantifying undetected imported cases, and evaluating the impact of lockdown measures in France and the proposal of exit strategies. [5] [6] Colizza and her team have been also investigating the effect of school closure and testing in the mitigation of COVID-19. [7] [8]

Awards and honors

Publications (selected)

Vittoria Colizza has published or co-published more than a hundred scientific articles at the end of 2020, including:

Related Research Articles

<span class="mw-page-title-main">Pandemic</span> Widespread, often global, epidemic of severe infectious disease

A pandemic is an epidemic of an infectious disease that has a sudden increase in cases and spreads across a large region, for instance multiple continents or worldwide, affecting a substantial number of individuals. Widespread endemic diseases with a stable number of infected individuals such as recurrences of seasonal influenza are generally excluded as they occur simultaneously in large regions of the globe rather than being spread worldwide.

<span class="mw-page-title-main">Spanish flu</span> 1918–1920 global influenza pandemic caused by the H1N1 influenza A virus

The 1918–1920 flu pandemic, also known as the Great Influenza epidemic or by the common misnomer Spanish flu, was an exceptionally deadly global influenza pandemic caused by the H1N1 subtype of the influenza A virus. The earliest documented case was March 1918 in the state of Kansas in the United States, with further cases recorded in France, Germany and the United Kingdom in April. Two years later, nearly a third of the global population, or an estimated 500 million people, had been infected in four successive waves. Estimates of deaths range from 17 million to 50 million, and possibly as high as 100 million, making it one of the deadliest pandemics in history.

<span class="mw-page-title-main">Influenza pandemic</span> Pandemic involving influenza

An influenza pandemic is an epidemic of an influenza virus that spreads across a large region and infects a large proportion of the population. There have been six major influenza epidemics in the last 140 years, with the 1918 flu pandemic being the most severe; this is estimated to have been responsible for the deaths of 50–100 million people. The 2009 swine flu pandemic resulted in under 300,000 deaths and is considered relatively mild. These pandemics occur irregularly.

<span class="mw-page-title-main">Alessandro Vespignani</span> Italian-American physicist (born 1965)

Alessandro Vespignani is an Italian-American physicist, best known for his work on complex networks, and particularly for work on the applications of network theory to the mathematical modeling of infectious disease, applications of computational epidemiology, and for studies of the topological properties of the Internet. He is currently the Sternberg Family Distinguished University Professor of Physics, Computer Science and Health Sciences at Northeastern University, where he is the director of the Network Science Institute.

<span class="mw-page-title-main">2009 swine flu pandemic</span> 2009–2010 pandemic of swine influenza caused by H1N1 influenza virus

The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, was the third recent flu pandemic involving the H1N1 virus. The first identified human case was in La Gloria, Mexico, a rural town in Veracruz. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".

<span class="mw-page-title-main">Social distancing</span> Infection control technique by keeping a distance from each other

In public health, social distancing, also called physical distancing, is a set of non-pharmaceutical interventions or measures intended to prevent the spread of a contagious disease by maintaining a physical distance between people and reducing the number of times people come into close contact with each other. It usually involves keeping a certain distance from others and avoiding gathering together in large groups.

<span class="mw-page-title-main">Pandemic H1N1/09 virus</span> Virus responsible for the 2009 swine flu pandemic

The pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media due to the prevailing belief that it originated in pigs. The virus is believed to have originated around September 2008 in central Mexico.

<span class="mw-page-title-main">1889–1890 pandemic</span> Global pandemic

The 1889–1890 pandemic, often referred to as the "Asiatic flu" or "Russian flu", was a worldwide respiratory viral pandemic. It was the last great pandemic of the 19th century, and is among the deadliest pandemics in history. The pandemic killed about 1 million people out of a world population of about 1.5 billion. The most reported effects of the pandemic took place from October 1889 to December 1890, with recurrences in March to June 1891, November 1891 to June 1892, the northern winter of 1893–1894, and early 1895.

<span class="mw-page-title-main">Ira Longini</span> American biostatistician

Ira M. Longini is an American biostatistician and infectious disease epidemiologist.

<span class="mw-page-title-main">Individual mobility</span> How humans move within a network

Individual human mobility is the study that describes how individual humans move within a network or system. The concept has been studied in a number of fields originating in the study of demographics. Understanding human mobility has many applications in diverse areas, including spread of diseases, mobile viruses, city planning, traffic engineering, financial market forecasting, and nowcasting of economic well-being.

The International School and Conference on Network Science, also called NetSci, is an annual conference focusing on networks. It is organized yearly since 2006 by the Network Science Society. Physicists are especially prominently represented among the participants, though people from other backgrounds attend as well. The study of networks expanded at the end of the twentieth century, with increasing citation of some seminal papers.

<span class="mw-page-title-main">Neil Ferguson (epidemiologist)</span> British epidemiologist and researcher

Neil Morris Ferguson is a British epidemiologist and professor of mathematical biology, who specialises in the patterns of spread of infectious disease in humans and animals. He is the director of the Jameel Institute, and of the MRC Centre for Global Infectious Disease Analysis, and head of the Department of Infectious Disease Epidemiology in the School of Public Health and Vice-Dean for Academic Development in the Faculty of Medicine, all at Imperial College London.

Azra Catherine Hilary Ghani is a British epidemiologist who is a professor of Infectious Disease Epidemiology at Imperial College London. Her research considers the mathematical modelling of infectious diseases, including malaria, bovine spongiform encephalopathy and coronavirus. She has worked with the World Health Organization on their technical strategy for malaria. She is associate director of the MRC Centre for Global Infectious Disease Analysis.

<span class="mw-page-title-main">Nahid Bhadelia</span> Indian-American infectious diseases physician and researcher

Nahid Bhadelia is an American infectious-diseases physician, founding director of Center for Emerging Infectious Diseases Policy and Research (CEID) at Boston University and an associate professor at the Boston University School of Medicine. She served as the Senior Policy Advisor for Global COVID-19 Response on the White House COVID-19 Response Team.

<span class="mw-page-title-main">Caitlin Rivers</span> American epidemiologist

Caitlin M. Rivers is an American epidemiologist who as Senior Scholar at the Johns Hopkins Center for Health Security and assistant professor at the Johns Hopkins Bloomberg School of Public Health, specializing on improving epidemic preparedness. Rivers is currently working on the American response to the COVID-19 pandemic with a focus on the incorporation of infectious disease modeling and forecasting into public health decision making.

Cécile Viboud is a Staff Scientist based in the Fogarty International Center at the National Institutes of Health, where she is part of the Multinational Influenza Seasonal Mortality Study (MISMS). Viboud specialises in the mortality of infectious disease. Viboud was involved with epidemiological analysis during the COVID-19 pandemic.

<span class="mw-page-title-main">Marc Lipsitch</span> American epidemiologist

Marc Lipsitch is an American epidemiologist and Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, where he is the Director of the Center for Communicable Disease Dynamics. He has worked on modeling the transmission of Coronavirus disease 2019 (COVID-19).

Each year since 2018, the Network Science Society selects up to 7 members of the network science community to be Fellows based on their enduring contributions to network science research and to the community of network scientists. Fellows are chosen from nominations received by the Network Science Society Fellowship Committee and are announced at the NetSci Conference hosted every year.

<span class="mw-page-title-main">Lone Simonsen</span> Danish epidemiologist (born 1959)

Lone Simonsen is a Danish epidemiologist and professor of population health sciences. Since the beginning of 2020, she has been the director of PandemiX, an interdisciplinary pandemic research center at Roskilde University. In 2023 PandemiX was established as a Center of Excellence funded by the Danish National Research Foundation.

Lyn Finelli is an American epidemiologist and infectious disease researcher, who helped lead the U.S. response to the 2009 H1N1 epidemic and contributed to research and public health communication about the COVID-19 pandemic. In 1990 Finelli was granted a doctorate in infectious disease epidemiology from Columbia University. She worked as chief of influenza surveillance and outbreak response at the Center for Disease Control. She led the CDC's response to the 2009 H1N1 outbreak and oversaw 200 employees. She was widely quoted in news coverage about the epidemic. Finelli now serves as executive director of new vaccine development at Merck Research Laboratories. In late March 2020, Finelli co-authored a paper published in the New England Journal of Medicine defining the epidemiology of COVID-19 and calling for further studies. Throughout her career, she has written over 100 scientific papers, book chapters, and articles on a variety of public health related topics, including RSV, sexual health, pneumonia, and hepatitis c.

References

  1. ↑ "Vittoria Colizza". ORCID. Retrieved 23 December 2020.
  2. ↑ Paul Benkimoun (2020-02-17). "Vittoria Colizza: the research virus" (in French). Retrieved 23 December 2020.
  3. ↑ "SUMO team: Communicable diseases: Surveillance and modelling". Pierre Louis Institute of Epidemiology and Public Health.
  4. ↑ "Vittoria Colizza". EPIcx Lab. Retrieved 23 December 2020.
  5. ↑ Francesco Pinotti; Laura Di Domenico; Ernesto Ortega; Marco Mancastroppa; Giulia Pullano; Eugenio Valdano; Pierre-Yves Boëlle; Chiara Poletto; Vittoria Colizza (2020-07-17). "Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study". PLOS Med. 7 (17): e1003193. doi: 10.1371/journal.pmed.1003193 . PMC   7367442 . PMID   32678827.
  6. ↑ Laura Di Domenico; Giulia Pullano; Chiara E. Sabbatini; Pierre-Yves Boëlle; Vittoria Colizza (2020). "Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies". medRxiv   10.1101/2020.04.13.20063933 .
  7. ↑ Colosi, Elisabetta; Bassignana, Giulia; Contreras, Diego Andrés; Poirier, Canelle; Boëlle, Pierre-Yves; Cauchemez, Simon; Yazdanpanah, Yazdan; Lina, Bruno; Fontanet, Arnaud; Barrat, Alain; Colizza, Vittoria (2022-07-01). "Screening and vaccination against COVID-19 to minimise school closure: a modelling study". The Lancet Infectious Diseases. 22 (7): 977–989. doi: 10.1016/S1473-3099(22)00138-4 . ISSN   1473-3099. PMC   8975262 . PMID   35378075. S2CID   247856752.
  8. ↑ Torneri, Andrea; Willem, Lander; Colizza, Vittoria; Kremer, Cécile; Meuris, Christelle; Darcis, Gilles; Hens, Niel; Libin, Pieter JK (2022-07-05). Leung, Kathy; van der Meer, Jos W; Young, Bernadette C (eds.). "Controlling SARS-CoV-2 in schools using repetitive testing strategies". eLife. 11: e75593. doi: 10.7554/eLife.75593 . ISSN   2050-084X. PMC   9255973 . PMID   35787310.
  9. ↑ "Lauréates 2021 du prix Irène Joliot-Curie : Julie Grollier, Vittoria Colizza, Odile Launay, Cécile Charrier et Odile Hembise Fanton d'Andon | Lauréats | Prix et médailles | Encourager la vie scientifique". www.academie-sciences.fr. Retrieved 2022-09-21.
  10. ↑ "Prix Louis-Daniel Beauperthuy" (PDF). Institut de France Academie des sciences. Retrieved 23 December 2020.
  11. ↑ "Vittoria Colizza receives the Young Scientist Award 2013". EPIcx Lab. Retrieved 23 December 2020.
  12. ↑ Kevin Fryling (2017-06-22). "Indiana University hosting world's largest conference on network science in Indianapolis". News at IU. Retrieved 23 December 2020.
  13. ↑ "Erdős-Rényi Prize". NetSci - The Network Science Society.
  14. ↑ "Vittoria Colizza receives the Telethon Farmindustria Award". EPIcx Lab. Retrieved 23 December 2020.
  15. ↑ "Vittoria Colizza (ISI Foundation, Inserm) receives the Telethon Farmindustria Award 2017". ISI Foundation & ISI Global Science Foundation. Retrieved 23 December 2020.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.